Clinical Trial Update: To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada.

View source ↗

Summary

A clinical trial update describing real-world use of intravitreal aflibercept and follow-up/treatment patterns for wet age-related macular degeneration and diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Wet Age-related Macular Degeneration

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Wet Macular Degeneration | Status: COMPLETED